Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 294
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05809557 | EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity | ||
| NCT04530695 | Diagnosis and Treatment of Periodontal Disease in Patients With AML | ||
| NCT01056601 | Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy | ||
| NCT00167219 | Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML) | ||
| NCT00176839 | Stem Cell Transplantation for Hematological Malignancies | ||
| NCT00625092 | Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies | ||
| NCT02988843 | Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors | ||
| NCT00725062 | Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant | ||
| NCT07493538 | MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases | ||
| NCT04090606 | Tobacco Constituents and Biomarkers | ||
| NCT02074631 | Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation | ||
| NCT02410239 | MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD) | ||
| NCT02500472 | Investigation of Kava Effects on NNK Metabolism | ||
| NCT06584929 | Rural Smoking Cessation | ||
| NCT01181258 | Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies | ||
| NCT02370160 | HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma | ||
| NCT00379197 | Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer | ||
| NCT05708924 | MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | ||
| NCT02948062 | Early Diagnosis Of Childhood Cerebral ALD | ||
| NCT02765997 | StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies | ||
| NCT04514471 | Feasibility Study - Filter Ventilation | ||
| NCT00855114 | Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery | ||
| NCT00005998 | Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | ||
| NCT00176878 | Stem Cell Transplant for Bone Marrow Failure Syndromes | ||
| NCT03674411 | Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy | ||
| NCT00287885 | Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer | ||
| NCT05735717 | MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies | ||
| NCT04228952 | Metabolism of NNK in Japanese Americans | ||
| NCT00818649 | Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia | ||
| NCT02118285 | Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | ||
| NCT00167206 | Stem Cell Transplantation for Fanconi Anemia | ||
| NCT01043640 | Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders | ||
| NCT05114837 | Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL | ||
| NCT00963872 | Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer | ||
| NCT06411795 | Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy | ||
| NCT01215981 | Influenza Vaccine Post Allogeneic Transplant | ||
| NCT01626092 | Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders | ||
| NCT00276159 | Study of Immune Response Modifier in the Treatment of Hematologic Malignancies | ||
| NCT00686556 | Total Marrow Irradiation for Refractory Acute Leukemia | ||
| NCT03609203 | Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal Training | ||
| NCT06594445 | HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML | ||
| NCT06213298 | Effect of Kava on Anxiety and Stress in Cancer Survivors | ||
| NCT01639456 | CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission | ||
| NCT03637972 | COMET2 Project 1 Filter Ventilation Study | ||
| NCT00643240 | Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Lymphocytic Leukemia | ||
| NCT00383448 | HSCT for High Risk Inherited Inborn Errors | ||
| NCT06030648 | MT2022-01: MSCs for ALD | ||
| NCT00176826 | T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders | ||
| NCT06692426 | Trial of Cell Based Therapy for DMD | ||
| NCT03294304 | BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy |
